SBI Life Insuran
SBI Life Insuran Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
0 of 2 strong
Not discussed on this call: capex, fundraise, order book.
The short version
SBI Life Insurance expects sustained growth in Individual Rated Premium (IRP) at around 14-15% annually. Value of New Business (VoNB) grew by 29% YoY to INR 14.1 billion, indicating strong future earnings growth potential.
From SBI Life Insuran's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- SBI Life Insurance expects sustained growth in Individual Rated Premium (IRP) at around 14-15% annually.
- Agency channel is gaining traction with 19%+ growth in the current quarter and anticipated stronger performance in upcoming quarters.
- Bancassurance (SBI and RRBs) contributes 47% to total APE, growing steadily at about 10%.
- Group business growth is lumpy but showing strong momentum (313% growth in group protection APE).
- Product mix is shifting towards higher-margin non-ULIP and pure protection products, supporting growth and profitability.
- New business premium grew 23% year-on-year; gross written premium up 20%.
- Assets under management increased by 10%, indicating expanding business volumes.
- The company aims to capitalize on regulatory changes positively affecting market conditions.
- Launch of new products (e.g., regular pay deferred annuity plans) expected next quarter contributing to growth.
Profitability & Margins
See what SBI Life Insuran said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what SBI Life Insuran said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
SBI Life Insuran — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.1K Cr, net profit ₹805 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What SBI Life Insurance Company Ltd's management said in earlier quarters
Others in Insurance this season
- Niva Bupa Health Insurance Company Ltd (Q1 FY27)
Group portfolio growth remains selective, focusing on profitable segments like SMEs growing over 50% (Page 6). Key concall takeaways from Niva Bupa Health…
- HDFC Life Insurance Company Ltd (Q1 FY27)
Agency channel growing strongly at around 21%, driven by new agents and branch expansion. Key concall takeaways from HDFC Life Insur.'s Q1 FY27 earnings call…
- Go Digit General Insurance Ltd (Q1 FY27)
Motor business is flat overall; strong growth in 2-wheeler segment (around 21-23%), but decline in commercial vehicles (-27%). Key concall takeaways from Go…
- ICICI Prudential Life Insurance Company Ltd (Q1 FY27)
Partnership distribution channel continues to be a key growth driver with a near 20% CAGR over the past five years; growth is broad-based across 1,000+…
Frequently Asked Questions
What were SBI Life Insuran Q1 FY27 results?
SBI Life Insurance expects sustained growth in Individual Rated Premium (IRP) at around 14-15% annually. Value of New Business (VoNB) grew by 29% YoY to INR 14.1 billion, indicating strong future earnings growth potential.
What is SBI Life Insuran share price analysis?
SBI Life Insuran currently shows a below-average growth signal. The stock trades at a P/E of 69.2 with a market cap of ₹179,875 Cr. Investors should review the full earnings analysis for detailed insights.
Is SBI Life Insuran planning capital expenditure?
The provided pages of the SBI Life Insurance Company Limited document do not mention any specific current or future capex, capital investment, or strategic investment plans.
Keep SBI Life Insuran on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
